HOME >> BIOLOGY >> NEWS
World's largest-ever sea turtle symposium to address plummeting populations of sea turtles

Washington, D.C., February 5, 2004 The largest-ever symposium about the preservation of sea turtles, featuring more than 1,100 of the world's leading experts on sea turtle conservation from 70 countries, will be held in San Jose, Costa Rica at the Herradura Hotel and International Conference Center from February 22 to 29, 2004.

The release of the 2004 State of the Sea Turtles report at the end of the symposium will offer the most up-to-date information on the status of the world's sea turtles.

The world's seven species of sea turtles are under grave danger from threats including over-fishing, destructive fishing practices such as long-lining and trawling of the ocean floor, and the poaching of turtle eggs, regarded by some cultures as an aphrodisiac.

The leatherback sea turtle, which can grow to nine feet in size and up to 2,000 pounds and pre-dates the dinosaur, is one of the species on the brink of extinction. In 1982, 115,000 reproductive female leatherbacks graced the coastlines of the Americas in the Pacific Ocean. Today, just two decades later, that number has plummeted more than 97 percent to fewer than 3,000. Scientists believe that strong conservation measures can still have a dramatic impact, but recognize that their window of opportunity is shrinking.

"Sea turtles, such as the Kemp's ridley and leatherback, have been adversely affected by human mismanagement of the environment," said Rod Mast, Vice President of Conservation International and President of the International Sea Turtle Symposium. "In the past few centuries, humans have decimated sea turtle populations through habitat destruction and exploitation. Now, sea turtle populations are declining due to fishing practices, pollution and global warming."

The 24th Annual Symposium on Sea Turtle Conservation and Biology will focus on specific strategies that can be implemented immediately to protect the world's remaining sea turtles. The theme
'"/>

Contact: Brad Phillips
b.phillips@conservation.org
202-912-1532
Conservation International
5-Feb-2004


Page: 1 2

Related biology news :

1. Worlds largest scientific society convenes regional meeting June 2-4 in Indianapolis
2. Worlds oldest modern hummingbirds described in Science
3. Worlds oldest mouse celebrates milestone birthday
4. Worlds largest tiger reserve declared in Myanmar
5. Worlds first databank for all living systems
6. Worlds first robot scientist proves a major success in the lab
7. Worlds leading mad cow diagnostic company, responds to USDAs additional BSE protection measures
8. Worlds largest scientific society holds regional meeting in Columbia, Mo.
9. Worlds most alkaline life forms found near Chicago
10. Worlds largest forest birds may produce worlds deepest bird calls
11. Worlds largest scientific society holds regional meeting in Long Beach, Calif.

Post Your Comments:
(Date:8/26/2015)... The report "Multi-Factor Authentication (MFA) Market ... (Travel & Immigration, Government, Banking, Defense, Commercial Security, Consumer ... published by MarketsandMarkets, Multi-Factor Authentication Market is expected to ... CAGR of 17.7% between 2015 and 2020. ... spread through 169 P ages and ...
(Date:8/24/2015)... CAPE TOWN, South Africa , August 24, 2015 /PRNewswire/ ... awarded Germany ,s largest biometrics manufacturer DERMALOG ... with the "2015 African Biometrics Company of the ... installation in Nigeria .   ... ) and http://www.presseportal.de/nr/8896 - On Thursday ...
(Date:8/20/2015)... Aug. 20, 2015 The wearable technology ... are active and healthy. However, wearable technology has ... environment to help improve diagnostic capabilities and therapeutic ... the Wearable Technologies Conference 2015 , where ... for wearables in healthcare.    "Over ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
(Date:8/26/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... quarter ended June 30, 2015. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... Oral Amp B program, rapidly advancing towards the ... Rae , President & CEO of iCo Therapeutics. "We ...
(Date:8/26/2015)... ... August 26, 2015 , ... Lee Biosolutions, a global ... and manufacture of highly valued cardiac markers used in early detection of heart ... protein chemistry has led to the development and commercialization of important cardiac biomarkers ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic company ... has received a $1.5M Phase II SBIR grant ... further develop its therapeutic agent to reduce arteriovenous ... in end stage renal disease (ESRD) patients undergoing ... Institute of Diabetes and Digestive and Kidney Diseases ...
(Date:8/26/2015)... and BEIJING , August 26, 2015 ... Scene with Impressive Acheivements  DiaCardio wins 1 st ... The competition, led in Israel ... featured 21 startups from countries including the US, China ... and Latin America .  Impressive ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6
Cached News: